A Search Service for Abbreviation / Long Form

â–  Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 777
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MPNST
Long Form : malignant peripheral nerve sheath tumor
No. Year Title Co-occurring Abbreviation
2020 A novel TJP1-ROS1 fusion in malignant peripheral nerve sheath tumor responding to crizotinib: A case report. SFT
2020 A Novel Treatment Modality for Malignant Peripheral Nerve Sheath Tumor Using a Dual-Effect Liposome to Combine Photodynamic Therapy and Chemotherapy. Ce6, NF1, PDT
2020 A rare case of malignant vagus nerve sheath tumor presenting with multiple cranial nerve dysfunction in a dog. ---
2020 Advanced pharmacological therapies for neurofibromatosis type 1-related tumors. NF1, RAS
2020 ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study. ---
2020 Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model. 3-BrPA, PA, ROS
2020 BRAF mutation, TERT promoter mutation, and HER2 amplification in sporadic or neurofibromatosis-related neurofibromas and malignant peripheral nerve sheath tumors: do these molecules have a signature in malignant transformation? NF
2020 Cdkn2a loss in a model of neurofibroma demonstrates stepwise tumor progression to atypical neurofibroma and MPNST. ANF, PN
2020 Combined inhibition of SHP2 and MEK is effective in models of NF1-deficient malignant peripheral nerve sheath tumors. MEKi, RAS-GAP, RTK
10  2020 Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In Vivo. ---
11  2020 Deregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumors. NF1
12  2020 Diagnosis and management of malignant peripheral nerve sheath tumors: Current practice and future perspectives. NF1
13  2020 Frequent MN1 Gene Mutations in Malignant Peripheral Nerve Sheath Tumor. MN1, NF, vRH-MPNST
14  2020 From Genes to -Omics: The Evolving Molecular Landscape of Malignant Peripheral Nerve Sheath Tumor. NF1, PRC2
15  2020 Functional imaging of RAS pathway targeting in malignant peripheral nerve sheath tumor cells and xenografts. PK, STS
16  2020 Giant Malignant Peripheral Nerve Sheath Tumor of the Head and Neck: A Case Report and Literature Review. ---
17  2020 Imaging of non-neurogenic peripheral nerve malignancy-a case series and systematic review. ---
18  2020 Interdisciplinary approach allows minimally invasive, nerve-sparing removal of retroperitoneal peripheral nerve sheath tumors. PNST
19  2020 KIF11 and KIF15 mitotic kinesins are potential therapeutic vulnerabilities for malignant peripheral nerve sheath tumors. ---
20  2020 Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities. NF1, RPPA
21  2020 Malignant Peripheral Nerve Sheath Tumor Arising From Transplanted Kidney Assessed by 18F-FDG PET/CT. ---
22  2020 Malignant peripheral nerve sheath tumor of the sciatic nerve presenting with leg pain in the setting of lumbar scoliosis and spinal stenosis. ---
23  2020 Malignant peripheral nerve sheath tumor: A rare malignancy. ---
24  2020 Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experience. ---
25  2020 Malignant peripheral nerve sheath tumors in children, adolescents, and young adults: Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry. CWS, EFS, IRS, OS
26  2020 Malignant peripheral nerve sheath tumour of the oesophagus: a case report. ---
27  2020 Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With 'Gradual Subtraction' ICE Chemotherapy. ICE, NF1
28  2020 Mixed malignant peripheral nerve sheath tumor in the inguinal region: a case report. EMPNSTs
29  2020 Molecular targets for NF1-associated malignant peripheral nerve sheath tumor. EED, NF1, PRC2, SUZ12
30  2020 Nek9,a sensitive immunohistochemical marker for Schwannian, melanocytic and myogenic tumours. RSs
31  2020 Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups. DFS, HG-MLPS, HT, LMS, OS, SS, STS, UPS
32  2020 Neurofibromatosis-associated malignant peripheral nerve sheath tumors in children have a worse prognosis: A nationwide cohort study. NCR, NF1, NRSTS, PALGA
33  2020 Ominous Occurrence of Spinal Intradural Primary Malignant Peripheral Nerve Sheath Tumor Four Decades following Radiation Therapy for Testicular Seminoma. ---
34  2020 Phase II clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors. CBR, OS, PFS, RECIST
35  2020 Polo-like kinase 1 as a therapeutic target for malignant peripheral nerve sheath tumors (MPNST) and schwannomas. AURKA, NF1, NF2, Plk1
36  2020 Primary malignant peripheral nerve sheath tumors arising from the spinal canal invading the abdominal cavity in a dog. ---
37  2020 Prognostic Significance of Histological Subtype in Soft Tissue Sarcoma With Distant Metastasis. STS
38  2020 RABL6A Is an Essential Driver of MPNSTs that Negatively Regulates the RB1 Pathway and Sensitizes Tumor Cells to CDK4/6 Inhibitors. CDK, RNA-Seq
39  2020 Radiation-associated sarcomas other than malignant peripheral nerve sheath tumours demonstrate loss of histone H3K27 trimethylation†. ---
40  2020 Resection of a Huge Intrathoracic Malignant Peripheral Nerve Sheath Tumor. ---
41  2020 Retroperitoneal malignant triton tumor in an infant: a case report and literature review. MTT
42  2020 Soft tissue sarcoma in neurofibromatosis type 1: A rare case of malignant peripheral nerve sheath tumor of the skin. NF
43  2020 Special Issue: "Genomics and Models of Nerve Sheath Tumors". ANNUBP, NF1
44  2020 Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors-A Sarcoma Reference Center Experience. OS, PFS
45  2020 Targeting Protein Translation by Rocaglamide and Didesmethylrocaglamide to Treat MPNST and Other Sarcomas. DDR, Roc
46  2020 The Novel Glutamine Antagonist Prodrug JHU395 Has Antitumor Activity in Malignant Peripheral Nerve Sheath Tumor. GA
47  2020 The Value of H3K27me3 Immunohistochemistry in Differentiating Malignant Peripheral Nerve Sheath Tumour with Its Histologic Mimickers. FNCLCC, GIST, H3K27me3, HUSM, IHC
48  2020 Treatment of neurofibromatosis 1-associated malignant peripheral nerve sheath tumors: a systematic review. CT, NF1, RT, SG
49  2020 Triton tumor of the orbit. ---
50  2020 Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle-based Chemotherapy in Pten-deleted Mouse Models of Sarcoma. CP-Dox, UPS
51  2020 Unmasking Intra-tumoral Heterogeneity and Clonal Evolution in NF1-MPNST. NF1
52  2020 [Retroperitoneal Dedifferentiated Liposarcoma which Could Be Diagnosed Using Dual Color in Situ Hybridization : A Case Report]. CT, MDM2
53  2019 A case of a malignant peripheral nerve sheath tumor in a guinea pig. ---
54  2019 A case of nodular fasciitis that was difficult to distinguish from sarcoma. ---
55  2019 A Phase II Trial of Sorafenib and Dacarbazine for Leiomyosarcoma, Synovial Sarcoma, and Malignant Peripheral Nerve Sheath Tumors. DCR, LMS, SS
56  2019 ALDH1 - A new immunohistochemical diagnostic marker for Schwann cell-derived tumors. ALDH1
57  2019 An unusual presentation of intraosseous malignant peripheral nerve sheath tumour of mandible. ---
58  2019 Arm malignant peripheral nerve sheath tumour: a rare clinical presentation. ---
59  2019 Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma. IHC, RMS
60  2019 Calebin-A induced death of malignant peripheral nerve sheath tumor cells by activation of histone acetyltransferase. AA, acetyl H3, EGCG, HAT, NF1
61  2019 Can we differentiate malignant peripheral nerve sheath tumor from benign neurofibroma without invasive sampling. NF1
62  2019 Carbon Ion Radiotherapy in the Management of the Tumors of the Peripheral Nervous System. CIRT
63  2019 Cardiac malignant peripheral nerve sheath tumor on computed tomography and magnetic resonance imaging: A case report. CMRI, CT, ECG
64  2019 Case Report: Metastasis of a Trigeminal Malignant Peripheral Nerve Sheath Tumor to the Corpus Callosum. ---
65  2019 Central nervous system metastasis of an intradural malignant peripheral nerve sheath tumor in a dog. ---
66  2019 Colonic malignant peripheral nerve sheath tumour in a cat. PCV, RI
67  2019 Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI. ADC, NF1, PNF, SUV
68  2019 Dumbbell malignant dorsal schwannoma embolized and operated by single posterior approach. ---
69  2019 Epigenomic Reordering Induced by Polycomb Loss Drives Oncogenesis but Leads to Therapeutic Vulnerabilities in Malignant Peripheral Nerve Sheath Tumors. FFPE, HDAC, PRC2, PTM
70  2019 Epithelioid Malignant Peripheral Nerve Sheath Tumor (Epithelioid-MPNST) Presenting as Bleeding Rectal Polyp: A Case Report with Systematic Literature Review. epithelioid-MPNST, Epithelioid-MPNST
71  2019 Frequency of Transducer-like Enhancer of Split 1 Immunohistochemical Expression in Synovial Sarcoma: An Institution-based Cross-sectional Study. EMA, ES, FS-DFSP, IHC, SD, SS, TLE1
72  2019 Identification of a Specific Translational Machinery via TCTP-EF1A2 Interaction Regulating NF1-associated Tumor Growth by Affinity Purification and Data-independent Mass Spectrometry Acquisition (AP-DIA). NF1, TCTP, VARS
73  2019 Immunohistochemical assessment of cyclin D1 and p53 is associated with survival in childhood malignant peripheral nerve sheath tumor. IHC, NF1, OS, RFS
74  2019 Intraosseous Malignant Peripheral Nerve Sheath Tumor of 2 Consecutive Lumbar Vertebrae: A Case Report and Literature Review. ---
75  2019 Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define pre-malignant neurofibromatosis type 1-associated atypical neurofibromas. ANF, NF1, PN, PRC2, WES
76  2019 Malignant peripheral nerve sheath tumor (MPNST) arising from angiosarcoma: a rare case report. ---
77  2019 Malignant peripheral nerve sheath tumor of the bladder A case report. NF1
78  2019 Malignant peripheral nerve sheath tumor of thigh with sphenoid and brain metastases: Extremely rare occurrence with dismal prognosis despite significant response to palliative chemoradiotherapy. NF1
79  2019 Malignant peripheral nerve sheath tumor: Transformation in a patient with neurofibromatosis type 2. NF, PNST
80  2019 Malignant peripheral nerve sheath tumors: Analysis of the national cancer database. NCDB, OS, STS
81  2019 Malignant Peripheral Nerve Sheath Tumors: From Epigenome to Bedside. EED, EZH2, NF1, PRC2, SUZ12
82  2019 Malignant peripheral nerve sheath tumour-A case report. ---
83  2019 Mediastinal malignant triton tumor: A rare case series and review of literature. MTT
84  2019 NFKB1-miR-612-FAIM2 pathway regulates tumorigenesis in neurofibromatosis type 1. FAIM2, miRNAs, NFKB1
85  2019 Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study. CSS, OS, SEER
86  2019 Non-cytotoxic systemic treatment in malignant peripheral nerve sheath tumors (MPNST): A systematic review from bench to bedside. MPNSTs
87  2019 Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study. EFS, EpSSG, NF1, OS
88  2019 Overcoming BET Inhibitor Resistance in Malignant Peripheral Nerve Sheath Tumors. NF1, PROTACs
89  2019 PD-1 Inhibition Achieves a Complete Metabolic Response in a Patient with Malignant Peripheral Nerve Sheath Tumor. PD-L1
90  2019 Pediatric peripheral nerve tumors: clinical and surgical aspects. BPNST, NF1, PNTs
91  2019 Personalizing surgical margins in retroperitoneal sarcomas: an update. DDLPS, LMS, RPS, SFT, WDLPS
92  2019 Poly Combs the Immune System: PRC2 Loss in Malignant Peripheral Nerve Sheath Tumors Can Dampen Immune Responses. PTM
93  2019 Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone. AS, MLS, SySa
94  2019 Primary Malignant Peripheral Nerve Sheath Tumor of the Trachea: a Case Report with Brief Review of Literature. CT
95  2019 Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST. MGH, OS
96  2019 Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors. CT, MR, PET, PN, SUV
97  2019 Sarcomas of the Oral and Maxillofacial Region: Analysis of 26 Cases with Emphasis on Diagnostic Challenges. CS, ES, LMS, MS, OS, PUS, RMS, SOMR
98  2019 Superficial malignant peripheral nerve sheath tumor from recurrent neurofibroma in the abdominal wall of a patient without neurofibromatosis type 1. NF1
99  2019 Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016). CBR, NF1, PR, pts, SD
100  2019 Transducer-like enhancer of split 1 (TLE1) as a novel biomarker for diagnosis of synovial sarcoma correlates with translocation t(X;18): a study of 155 cases in China. FISH, SS, TLE1